Mitsubishi Electric Announces Dividend for Fiscal 2025 (April 1, 2024 – March 31, 2025) and Dividend Forecast for Fiscal 2026 (April 1, 2025 – March 31, 2026)
TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO:6503) announced today that the Board of Directors has resolved to pay a year-end dividend... Read more.
TreeFrog Therapeutics Presents Delivery Strategy for Next Generation 3D Cell Therapy Format for Parkinson’s Disease at the 28th Annual ASGCT Meeting in New Orleans
TreeFrog Therapeutics is the first company to present publicly a clinical-ready delivery strategy for 3D format microtissues in cell therapy. After four years in... Read more.
Eastnets Double Award Win at 2025 MEA Finance Banking Technology Awards
DUBAI, United Arab Emirates–(BUSINESS WIRE)–Eastnets, a global leader in compliance, payments, and cloud solutions, has been crowned winner of two awards... Read more.
Ranpak Expands its Global Footprint Through Large-Scale Sustainable Packaging Partnership with Thalia
Leading international book retailer partners with Ranpak to boost efficiency and reduce environmental impact across its more than 500 stores and ecommerce operations.... Read more.
New Wellness Clinic, Pacific Northwest Massage and Body Restoration, Bringing Insurance-Based Massage and Cutting-Edge Recovery Therapies to Bellevue
Grand Opening This June to Feature Free Services, Pop-Up Eats, Special Guest Appearance, and Advanced Wellness Tech BELLEVUE, Wash.–(BUSINESS WIRE)–#3dbodyscanner–Pacific... Read more.
Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders
Financing round led by Jeito Capital and co-led by Forbion Growth, with participation from Seroba, Pictet Group and other existing investors Proceeds to fund two... Read more.
Ten-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast Cancer
– Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab)... Read more.
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
€15 million investment by Sanofi, in addition to the ongoing partnership including the development of BCMA targeting ANKET® program in autoimmune indications... Read more.
Burkhan World Investments Announces $15 Billion in Strategic Memoranda of Understanding with Saudi Arabia Across Mining, AI, and Dual-Purpose Defense Technologies
Signed at USA-Saudi Strategic Investment Forum During President Donald J. Trump’s Delegation Visit to Riyadh MIAMI–(BUSINESS WIRE)–Burkhan World... Read more.
Infleqtion Unveils Open-Source Library for Quantum Error Correction Research
Release of new open source quantum software library accelerates research towards unlocking 10–100x reductions in qubit requirements and clearing a key hurdle for... Read more.